Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Sep 2016 Planned End Date changed from 1 May 2016 to 1 May 2017.
- 07 Nov 2015 Planned End Date changed from 1 May 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.